Loading the map…

Buying and selling of own real estate · Edgware

NW7 Developments

NW7 Developments Limited

Net liabilitiesActiveLatest figures: 2024Abridged accountsCompany only4 years on the register

Private limited company registered in Edgware, classed under “Buying and selling of own real estate” and 1 other activity.

Headline figures

FY to Apr 2024 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

What the numbers say

2 findings from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

History

Pro
£20222024
Profit after tax—
Turnover
Net assets
Cash
Employees

Every figure for all 2 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

Balance sheet and ratios

From the filed balance sheets · £

Balance sheet20222024
Current assets
Creditors due within a year
Net assets
Ratios
Current ratioCurrent assets for every £1 owed within a year

3 balance-sheet lines and 1 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

Questions people ask

›What does NW7 Developments do?

Private limited company registered in Edgware, classed under “Buying and selling of own real estate” and 1 other activity.

›How much turnover does NW7 Developments make?

Answered in the full report

›Is NW7 Developments profitable?

NW7 Developments's profit isn't public: small companies may file without a profit and loss account.

›How many people work at NW7 Developments?

Answered in the full report

›Where is NW7 Developments based?

Its registered office is 42-46 Station Road, Edgware, HA8 7AB, in Edgware.

›When was NW7 Developments founded?

NW7 Developments Limited was incorporated on 30 December 2021.

›Is NW7 Developments still trading?

The register lists NW7 Developments Limited as active.